Kronox Lab Surges on Debut, Lists at ₹165 with 21% Premium!

Kronox Lab Sciences debuted strongly on the stock market, opening at ₹165 on BSE and ₹164.95 on NSE, both over 21% above the IPO price.
Kronox Lab Surges on Debut, Lists at ₹165 with 21% Premium

Kronox Lab Sciences made a notable entrance on the stock market, with shares listed at ₹165 on the BSE and ₹164.95 on the NSE, over 21% above the IPO price of ₹136. The company experienced vigorous trading on its first day of listing.

Kronox Lab Sciences’ IPO, valued at ₹130.15 crore, was open June 3 to 5 with a price range of ₹129 to 136. It attracted massive interest, being oversubscribed 117.25 times, with notable demand from NIIs, QIBs, and retail investors, highlighting robust market enthusiasm.

Kronox Lab Science manufactures high-purity specialty chemicals for various sectors such as pharmaceuticals and agrochemicals. Offering a diverse product lineup of over 185 chemicals, the company ensures quality and continuous improvement, securing recurring orders. With facilities in Gujarat and exports to over 20 countries, Kronox has seen significant export revenue growth, underlining its global reach and operational excellence.

Kronox Lab Sciences’ IPO aims to allocate ₹30.40 crores for working capital to expand products and markets in Fiscal 2025. The remaining funds will enhance corporate functions, including sales, staffing, capital improvements, and legal expenditures.

Read More News




Trade Intraday and Futures & Options